MétaCan
Menu
Back to cohort
Record W4412187071 · doi:10.1038/s41375-025-02664-w

2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia

2025· article· en· W4412187071 on OpenAlexaff
Jane F. Apperley, Dragana Milojković, Nicholas C.P. Cross, Henrik Hjorth‐Hansen, Andreas Hochhaus, Hagop M. Kantarjian, Jeffrey H. Lipton, Hemant Malhotra, Dietger Niederwieser, Jerald P. Radich, Philippe Rousselot, Susanne Saußele, Charles A. Schiffer, Richard T. Silver, Simona Soverini, Leif Stenke, Anna Turkina, Luis Felipe Casado, Fausto Castagnetti, Francisco Cervantes, Richard E. Clark, Jörge E. Cortes, Michael W. Deininger, Timothy P. Hughes, Jeroen J. W. M. Janssen, Qian Jiang, Dong‐Wook Kim, Richard A. Larson, François Xavier Mahon, Michael J. Mauro, Jiřı́ Mayer, Franck E. Nicolini, Fabrizio Pane, Delphine Réa, Johan Richter, Gianantonio Rosti, Giuseppe Saglio, Rüdiger Hehlmann

Bibliographic record

VenueLeukemia · 2025
Typearticle
Languageen
FieldMedicine
TopicChronic Myeloid Leukemia Treatments
Canadian institutionsPrincess Margaret Cancer CentreUniversity of Toronto
Fundersnot available
KeywordsMedicineDiscontinuationDosingIntensive care medicineDiseaseTransplantationMyeloid leukemiaQuality of life (healthcare)Tyrosine-kinase inhibitorDisease managementMEDLINEFamily medicineInternal medicineCancer

Abstract

fetched live from OpenAlex

In this 5th version of the European LeukemiaNet guidance for adult patients, there are important changes in several areas of management based on evidence available since 2020, including the World Health Organisation's reclassification of CML as a biphasic disease. Previous advice to switch the tyrosine kinase inhibitor (TKI) on failure of molecular milestones, is modified to better account for individual patient circumstances. Our recommendations are summarized in tables designed to be read in conjunction with the text which offers justification and additional advice. We describe decision-making for first-line treatment, both in available drugs and their initial dosing. Similarly we elaborate on dose reduction rather than drug switching to manage toxicities and discuss treatment sequencing. Data have matured for the outcome of treatment discontinuation and for management of parenting for both men and women. We acknowledge that most patients will remain on treatment for many years and emphasize the needs to minimize side effects, manage co-morbidities and optimize quality of life. Recent advances in allogeneic stem cell transplantation have broadened access to alternative donors, and lessened limitations of age and co-morbidities such that transplant remains a valuable option for patients for whom long-term disease control is not achieved through TKI therapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.684
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.298
Teacher spread0.275 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations80
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueLeukemiaSame topicChronic Myeloid Leukemia TreatmentsFrench-language works237,207